EC backs voluntary COVID-19 vaccine licensing
18-06-2020
BIO 2020: IP’s vital role in COVID-19 fight, potential ‘chaos’ of pooling
09-06-2020
akedesign / Shutterstock.com
The leaders of some of the world’s largest pharma companies appear to be resistant to a World Health Organization (WHO) voluntary pool aimed at making vaccines, tests, treatments and other health technologies to fight COVID-19 accessible to all.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
